Related content

Targeted Toxins for Glioblastoma Multiforme: Pre-Clinical Studies and Clinical Implementation

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 11, Iss. 8, 2011-10 ,pp. : 729-738

Bentham Science Publishers

Access to resources Recommend Favorite

Vitespen: a preclinical and clinical review

By Wood Christopher G   Mulders Peter  

Future Oncology, Vol. 5, Iss. 6, 2009-08 ,pp. : 763-774

Future Medicine

Access to resources Recommend Favorite

Hyperthermia, cisplatin and radiation trimodality treatment: A promising cancer treatment? A review from preclinical studies to clinical application

By Bergs J. W. J.   Franken N. A. P.   Haveman J.   Geijsen E. D.   Crezee J.   van Bree C.  

International Journal of Hyperthermia, Vol. 23, Iss. 4, 2007-01 ,pp. : 329-341

Informa Healthcare

Access to resources Recommend Favorite

Forodesine: review of preclinical and clinical data

By Al-Kali Aref   Gandhi Varsha   Ayoubi Mohamad   Keating Michael   Ravandi Farhad  

Future Oncology, Vol. 6, Iss. 8, 2010-08 ,pp. : 1211-1217

Future Medicine

Access to resources Recommend Favorite

Targeted Therapies in Metastatic Melanoma: Toward a Clinical Breakthrough?

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 10, Iss. 9, 2010-11 ,pp. : 661-665

Bentham Science Publishers

Access to resources Recommend Favorite